Sabby Management, LLC Eyenovia, Inc. Transaction History

Sabby Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.11 - $6.06 $1.89 Million - $3.69 Million	-608,720 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.61 - $5.1 $1.59 Million - $3.1 Million	608,720 New	608,720 $1.9 Million
Q4 2019 Feb 14, 2020	SELL	$2.67 - $4.48 $47,793 - $80,192	-17,900 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$2.55 - $4.91 $80,580 - $155,156	-31,600 Reduced 63.84%	17,900 $66,000
Q2 2019 Aug 14, 2019	SELL	$4.08 - $6.87 $65,280 - $109,920	-16,000 Reduced 24.43%	49,500 $213,000
Q1 2019 May 15, 2019	SELL	$2.63 - $6.3 $293,534 - $703,143	-111,610 Reduced 63.02%	65,500 $392,000
Q4 2018 Feb 14, 2019	BUY	$2.6 - $4.24 $35,757 - $58,312	13,753 Added 8.42%	177,110 $505,000
Q3 2018 Nov 14, 2018	BUY	$4.02 - $7.22 $117,355 - $210,773	29,193 Added 21.76%	163,357 $657,000
Q2 2018 Aug 14, 2018	BUY	$6.25 - $9.49 $227,462 - $345,379	36,394 Added 37.22%	134,164 $845,000
Q1 2018 May 15, 2018	BUY	$8.11 - $9.95 $792,914 - $972,811	97,770 New	97,770 $908,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $2.74M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.